| Literature DB >> 35186250 |
Dereje Gebeyehu Ababu1, Azmeraw Misganaw Getahun1.
Abstract
INTRODUCTION: Every year worldwide, between five to six million deaths are associated with stroke; on average, one stroke-related death occurs every four minutes. In Ethiopia, stroke is a frequent cause of mortality and morbidity from noncommunicable diseases. Therefore, this study was aimed at determining factors associated to stroke mortality through survival models in Mettu Karl Referral Hospital.Entities:
Year: 2022 PMID: 35186250 PMCID: PMC8856786 DOI: 10.1155/2022/9985127
Source DB: PubMed Journal: Stroke Res Treat
Baseline covariate characteristics with their time-to-death status.
| Variables | Categories | Frequency | Death (%) | Censored (%) | Mean (days) | [95% CI] |
|---|---|---|---|---|---|---|
| Gender | Male | 120 (59.4%) | 34 (55.7%) | 86 (61%) | 9.179131 | [8.04889, 10.3094] |
| Female | 82 (40.6%) | 27 (44.3%) | 55 (39%) | 5.150107 | [4.22813, 6.07208] | |
| Blood pressure | Yes | 123 (60.9%) | 44 (72.13%) | 77 (54.6%) | 5.761887 | [5.15259, 6.37119] |
| No | 79 (39.1%) | 17 (27.87%) | 64 (45.4%) | 9.764186 | [8.30564, 11.2227] | |
| Cardiac disease | Yes | 26 (12.9%) | 11 (20%) | 15 (10.2%) | 8.069148 | [5.14086, 10.9974] |
| No | 176 (87.1%) | 44 (80%) | 132 (89.8%) | 7.770081 | [6.85184, 8.68832] | |
| Diabetes mellitus | Yes | 15 (7.4%) | 3 (5.45%) | 12 (8.2%) | 6.289487 | [4.67067, 7.9083] |
| No | 187 (92%) | 52 (94.54%) | 135 (91.8%) | 7.918552 | [6.98651, 8.8506] | |
| Stroke type | Hemorrhagic | 70 (34.7%) | 29 (52.73%) | 41 (27.9%) | 6.137696 | [5.17646, 7.09893] |
| Ischemic | 117 (57.9%) | 23 (41.82%) | 94 (63.9%) | 8.719683 | [7.5657, 9.87366] | |
| Both | 15 (7.4%) | 3 (5.45%) | 12 (8.2%) | 4.584416 | [3.25288, 5.91595] | |
| Baseline complication | Yes | 115 (56.9%) | 37 (67.3%) | 78 (53%) | 5.391817 | [4.83329, 5.95035] |
| No | 87 (43.1%) | 18 (32.7%) | 69 (47%) | 9.92229 | [8.54041, 11.3042] |
Figure 1Overall Kaplan-Meier survivor function.
Figure 2K-M plot survival of time-to-death by hypertension of stroke patients.
Log rank tests of each covariate.
| Variable | Log rank test | ||
|---|---|---|---|
| Chi.sq | Df |
| |
| Gender | 27.4 | 1 | <0.001 |
| Age | 100 | 52 | <0.001 |
| Cardiac disease | 0 | 1 | 0.988 |
| Diabetes mellitus | 0.9 | 1 | 0.341 |
| Blood pressure (hypertension) | 22.3 | 1 | <0.001 |
| Drug type | 9.4 | 6 | 0.152 |
| Baseline complication | 31.4 | 1 | <0.001 |
| Stroke type | 8.1 | 2 | 0.150 |
Summary univariable (single covariate) Cox PH analysis.
| Covariate | Category | Coef ( | HR | se ( | Wald | Pr (>∣ | 95% CI |
|---|---|---|---|---|---|---|---|
| Age | 0.011662 | 1.011731 | 0.004634 | 6.33 | 0.012 | [1.003, 1.0210] | |
| Gender | 0 female | Ref | |||||
| -0.8860 | 0.4123 | 0.1845 | 23.05 | <0.001 | [0.2872, 0.5920] | ||
| Cardiac disease | 0 no | Ref | |||||
| -0.003844 | 0.996164 | 0.273690 | -0.014 | 0.989 | [0.5826, 1.7030] | ||
| Diabetes mellitus | 0 no | Ref | |||||
| 0.2712 | 1.3116 | 0.3046 | 0.79 | 0.373 | [0.7219, 2.3830] | ||
| Hypertension | 0 no | Ref | |||||
| 0.9365 | 2.5510 | 0.1986 | 22.24 | <0.001 | [1.7290, 3.7650] | ||
| Stroke type | 0 (hemorrhagic) | Ref | |||||
| -0.4857 | 0.6152 | 0.1976 | -2.458 | 0.014 | [0.4177, 0.9062] | ||
| 0.5496 | 1.7325 | 0.3303 | 13.44 | 0.096 | [0.9068, 3.3101] | ||
| Baseline complication | 0 no | Ref | |||||
| 1.1220 | 3.0710 | 0.2056 | 29.78 | <0.001 | [2.052, 4.5950] |
Summary multivariable Cox PH analysis to the stroke data set from the MCRH.
| Covariates | Category | Coef ( | Haz. ratio | Std. Err. ( | Wald |
| [95% Conf. Interval HR] |
|---|---|---|---|---|---|---|---|
| Age | 0.0051853 | 1.0051988 | 0.0052631 | 0.985 | 0.325 | [0.9949, 1.0156] | |
| Gender | 0 female | Ref | |||||
| -0.7226692 | 0.4854547 | 0.1937196 | -3.730 | <0.001 | [0.3321, 0.7096] | ||
| Blood pressure | 0 no | Ref | |||||
| 0.6713666 | 1.9569097 | 0.2145444 | 3.129 | 0.002 | [1.2851, 2.9798] | ||
| Baseline complication | 0 (no) | Ref | |||||
| 0.5218596 | 1.6851584 | 0.2236382 | 2.333 | 0.020 | [1.0871, 2.6122] | ||
| Stroke type | 0 (hemo) | Ref | . | . | |||
| -0.2105377 | 0.8101485 | 0.2094069 | -1.005 | 0.315 | [0.5374, 1.2213] |
Figure 3Plots of the martingale residuals against the covariate age.
Schoenfeld residual for each covariate.
| Covariates | Categories | Rho | Chi2 | Prob > chi2 |
|---|---|---|---|---|
| Age | 0.0462 | 0.2586 | 0.611 | |
| Gender | Female ref | |||
| Male | 0.0304 | 0.1364 | 0.712 | |
| Hypertension | No ref | |||
| Yes | 0.1115 | 2.3567 | 0.125 | |
| Baseline complication | No ref | |||
| Yes | 0.0625 | 0.8123 | 0.367 | |
| Drug type | Nondrug (ref) | |||
| Drug type 1 | -0.0974 | 1.3874 | 0.239 | |
| Drug type 2 | -0.0573 | 0.4887 | 0.485 | |
| Drug type 3 | -0.0111 | 0.0177 | 0.894 | |
| Drug type 4 | -0.0374 | 0.1989 | 0.656 | |
| Drug type 5 | -0.0445 | 0.2939 | 0.588 | |
| Stroke type | 0 ref | |||
| Stroke type 1 | -0.0229 | 0.0874 | 0.768 | |
| Stroke type 2 | 0.0360 | 0.1898 | 0.663 | |
| Global test | 8.4942 | 0.668 |
The likelihood ratio and significance of the PH model.
| Covariate | Coef ( | HR | se ( | Wald |
|
|---|---|---|---|---|---|
| Factor (gender) 1 | -0.712 | 0.491 | 0.193 | -3.69 | <0.001 |
| Factor (BP) 1 | 0.654 | 1.923 | 0.208 | 3.15 | 0.002 |
| Factor (baseline) 1 | 0.666 | 1.947 | 0.218 | 3.06 | 0.002 |
Likelihood ratio test = 49.8 on 3 DF; P = 8.87e − 11; n = 202; number of events = 147.